Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection
Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection. // Chinese Journal of Natural Medicines. – URL: https://www.sciencedirect.com/science/article/pii/S2666354626002292?dgcid=rss_sd_all
Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection. Chinese Journal of Natural Medicines. https://www.sciencedirect.com/science/article/pii/S2666354626002292?dgcid=rss_sd_all
“Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection.” Chinese Journal of Natural Medicines.
@article{article13719,
title = {Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection},
journal = {Chinese Journal of Natural Medicines},
url = {https://www.sciencedirect.com/science/article/pii/S2666354626002292?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Brain, Behavior, & Immunity - Health, Volume 58 Author(s): AmirAli Bigleri, Emmanuel T. Alimo, Amal Abouda, Mohammed Osman, Jan Willem Cohen Tervaert, Shokrollah Elahi
Publication date: December 2026 Source: Brain, Behavior, & Immunity - Health, Volume 58 Author(s): Jason Lunzhe Cui, Muge Kalaycioglu, Giorgio Camillo Ricciardiello Mejia, Lu Tian, Linda N. Geng, Grace McComsey, Vincent Macorni, Jacob...
Publication date: December 2026 Source: Brain, Behavior, & Immunity - Health, Volume 58 Author(s): Ted K.S. Ng, Kyle R. Dennis, Todd Beck, Jerenda Bond, Kristin R. Krueger, Pankaja Desai, Robert S. Wilson, Denis A. Evans, Kumar B. Rajan